OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2022
Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
CDMOs offer expertise and capacity for spray drying.
CDMOs offer expertise and customization options for sponsors of orphan drugs.
Pharmaceutical Technology Europe's BioPharma Outsourcing Innovation supplement examines outsourcing development services, spray draying, capacity challenges, and more.
January 28, 2022
Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.
Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.
January 21, 2022
Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals
Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.
January 18, 2022
After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.